albendazole has been researched along with zithromax in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chearskul, S; Chokephaibulkit, K; Pavitpok, J; Tosasuk, K; Vanprapar, N; Wanachiwanawin, D | 1 |
| Amsden, GW; Glue, P; Gregory, TB; Knirsch, CA; Michalak, CA | 1 |
| Campagna, AM; Patnaik, MM; Walker, PF | 1 |
| Coulibaly, YI; Daou, A; Dicko, I; Doumbia, M; Haidara, FC; Horton, J; Keita, M; Keita, MM; Sankare, MH; Sow, SO; Whately-Smith, C | 1 |
| Adam, P; Altmann, M; Artaud, C; Briend, A; Hedible, BG; Jambou, R; Mainassara, H; Manirazika, A; Randremanana, R; Tondeur, L; von Platen, C; Vray, M | 1 |
| Callaghan-Gillespie, M; Hendrixson, DT; Iversen, PO; Koroma, AS; Lasowski, P; Manary, MJ; Papathakis, P; Smith, K; Weber, J | 1 |
| Bougma, R; Drabo, F; Gass, K; Jose, R; Mkwanda, S; Tukahebwa, EM | 1 |
| Gebre, T; Mabey, DCW; Marks, M; McPherson, S; Seife, F; Solomon, AW; Solomon, H | 1 |
| Aseffa, A; Behaksira, S; Debebe, K; Gadisa, E; Gebre, T; Geleta, D; Gemechu, L; Kebede, B; Kebede, F; Mabey, DCW; Mammo, B; Marks, M; McPherson, S; Miecha, H; Oljira, B; Seife, F; Solomon, AW; Solomon, H; Tadesse, F; Tafese, G; Tafese, T | 1 |
2 review(s) available for albendazole and zithromax
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
Topics: Albendazole; Azithromycin; Drug Therapy, Combination; Elephantiasis, Filarial; Feasibility Studies; Humans; Ivermectin; Mass Drug Administration; Neglected Diseases | 2023 |
4 trial(s) available for albendazole and zithromax
| Article | Year |
|---|---|
Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers.
Topics: Adult; Albendazole; Animals; Anti-Bacterial Agents; Antiparasitic Agents; Area Under Curve; Azithromycin; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Ivermectin; Male | 2007 |
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Bacterial Agents; Azithromycin; Chemoprevention; Child; Child, Preschool; Coinfection; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Mali; Middle Aged; Neglected Diseases; Trachoma; Young Adult | 2013 |
A multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project).
Topics: Acute Disease; Africa; Age Factors; Albendazole; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Child Development; Child, Preschool; Female; Flour; Food, Fortified; Gastrointestinal Microbiome; Humans; Infant; Infant Nutrition Disorders; Infant Nutritional Physiological Phenomena; Male; Malnutrition; Multicenter Studies as Topic; Nutritional Status; Prebiotics; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2018 |
A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
Topics: Adolescent; Adult; Albendazole; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Dysbiosis; Female; Food Assistance; Humans; Infection Control; Malaria; Malnutrition; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Care; Prospective Studies; Sierra Leone; Vaginal Diseases; Young Adult | 2021 |
9 other study(ies) available for albendazole and zithromax
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Child; Diarrhea; HIV Seronegativity; HIV Seropositivity; Humans; Intestinal Diseases, Parasitic; Prevalence; Prospective Studies; Thailand | 2001 |
Neglected tropical disease: challenges, progress, and hope.
Topics: Albendazole; Azithromycin; Developing Countries; Drug Costs; Drug Industry; Drug Therapy, Combination; Emigrants and Immigrants; Financial Management; Humans; Ivermectin; Mebendazole; Minnesota; Praziquantel; Tropical Medicine; United States | 2008 |
Proxy Responses for Mass Drug Administration Coverage Surveys: The Trends and Biases When Others are Allowed to Respond.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Burkina Faso; Child; Demography; Female; Humans; Ivermectin; Logistic Models; Malawi; Male; Mass Drug Administration; Mental Recall; Praziquantel; Proxy; Uganda; Young Adult | 2021 |
Perceptions and acceptability of co-administered albendazole, ivermectin and azithromycin mass drug administration, among the health workforce and recipient communities in Ethiopia.
Topics: Adolescent; Albendazole; Azithromycin; COVID-19; COVID-19 Drug Treatment; Ethiopia; Health Workforce; Humans; Ivermectin; Mass Drug Administration | 2023 |